RxSight (NASDAQ:RXST) Receives “Buy” Rating from Needham & Company LLC
Needham & Company LLC restated their buy rating on shares of RxSight (NASDAQ:RXST – Free Report) in a research report released on Thursday morning,Benzinga reports. They currently have a $43.00 target price on the stock. Other research analysts have also recently issued research reports about the company. Wells Fargo & Company cut their price objective […]
Needham & Company LLC restated their buy rating on shares of RxSight (NASDAQ:RXST – Free Report) in a research report released on Thursday morning,Benzinga reports. They currently have a $43.00 target price on the stock. Other research analysts have also recently issued research reports about the company. Wells Fargo & Company cut their price objective […]
